The Innovation Multidisciplinary
Individualized mRNA vaccine combination meets RFS and DMFS endpoints at a prespecified phase 3 interim analysis
The publisher did not provide an abstract — full text is available via the link below.
The Innovation Multidisciplinary
The publisher did not provide an abstract — full text is available via the link below.